Group 1 - The core viewpoint of the articles emphasizes that technology sectors, particularly artificial intelligence and innovative pharmaceuticals, are driving the structural market trends in A-shares this year, and these areas are expected to remain long-term focal points for investment [1][12]. - The concept of "smart living" is introduced, which refers to the comprehensive intelligent upgrade of daily life through big data and AI, enhancing convenience, efficiency, and personalization in various life scenarios [5]. - The rise of autonomous driving technology is highlighted, showcasing its potential to improve traffic safety and efficiency through advancements in AI, sensors, and communication technologies, indicating a significant growth opportunity in the automotive sector [9]. Group 2 - AI-driven pharmaceuticals are emerging as a new model in drug development, significantly reducing costs and time associated with traditional drug development processes, thus attracting investment interest in the pharmaceutical and technology sectors [12]. - The integration of technology into everyday life is reshaping consumer behavior and creating substantial market opportunities, as companies continue to innovate in this space [5]. - The upcoming introduction of the Sci-Tech Innovation Board Index is mentioned as a tool for investors to capitalize on technology opportunities in the evolving smart era [15].

Core Viewpoint - The article emphasizes the rapid growth and significance of the Sci-Tech Innovation Board (科创板) in China's economic transformation, highlighting its role as a breeding ground for new productive forces and a witness to the fast development of high-tech sectors in China [2][4]. Group 1: Growth of Sci-Tech Innovation Board - Since its inception, the number of listed companies on the Sci-Tech Innovation Board has increased more than sevenfold, reaching 585 companies, while the total market capitalization has grown over eightfold to approximately 8309.175 billion yuan as of March 11, 2025 [2]. - The board is seen as a crucial force in the development of new productive forces, aligning with China's economic transformation [4]. Group 2: Industry Distribution and Characteristics - The Sci-Tech Innovation Board includes a diverse range of industries, with a significant focus on "hard technology," covering 17 primary industries such as electronics, biomedicine, and computer technology [16][18]. - The distribution of companies is balanced, with 44.5% in electronics, 15.2% in biomedicine, and 9.7% in computing, indicating a strong presence in emerging sectors [18]. Group 3: Investment Products and Strategies - The article introduces various investment products targeting the Sci-Tech Innovation Board, including the comprehensive ETF and Smart Beta indices, which aim to capture overall investment opportunities and enhance alpha returns through quality and valuation metrics [10][22][26]. - The Sci-Tech 200 Index focuses on smaller-cap stocks, with 82% of its sample stocks having a market capitalization below 10 billion yuan, indicating growth potential in smaller companies [27][28]. Group 4: Performance Metrics - The performance of the selected indices since 2020 shows significant volatility, with the Smart Beta index achieving a return of 78.76% in 2020, followed by varying returns in subsequent years [25]. - The article highlights the importance of focusing on companies with strong innovation capabilities and consistent R&D investment to ensure stable performance [23].